Latest Acelot News & Updates
See the latest news and media coverage for Acelot. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotech developing small molecules for neurodegenerative diseases
acelot.com- Headquarters
- South San Francisco, United States
- Company type
- Private company
- Number of employees
- 2–30
Last updated
Latest news about Acelot
Company announcements
-
Acelot presents ACE-2223 progress at NEALS
CEO Dr. Katie Planey speaks on October 8th at 2pm ET in Florida. Poster 151 follows on October 9th. FIH trials start next year.
-
Acelot collaborates with TargetALS
Highlighted in their report on companies targeting TDP-43 dysfunction in ALS. Innovates in therapeutic development and TDP-43 quantification methods.
Media coverage
Never miss news about Acelot
Track Acelot and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Acelot competitors & trending companies
Browse news for competitors to Acelot and other trending companies.
Neurizon Therapeutics
Transposon Therapeutics
Raya
Origami Therapeutics
Revalesio
QurAlis
Vesalic
Mitochon Pharmaceuticals
NeuroSense Therapeutics
Harness Therapeutics
Aquilus Pharmaceuticals
Aperture Therapeutics
Andon Labs
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire